Back to all journals
journal articles
VIEWPOINT: WHAT IS REASONABLE AND NECESSARY FOR PEOPLE LIVING WITH AD AFTER THE FDA APPROVES A TREATMENT?
R.S. Doody, S. Skerjanec
J Prev Alz Dis 2023;3(10):344-345
CITATION:
R.S. Doody ; S. Skerjanec ; ; (2023): Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?. The Journal of Prevention of Alzheimer’s Disease (JPAD). http://dx.doi.org/10.14283/jpad.2023.74